Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 13,619 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
Follow-Up Questions
GRRMY 주식의 가격 성능은 어떻습니까?
GRRMY의 현재 가격은 $8.2이며, 전 거래일에 decreased 0% 하였습니다.
Gerresheimer AG의 주요 사업 주제나 업종은 무엇입니까?
Gerresheimer AG은 Life Sciences Tools & Services 업종에 속하며, 해당 부문은 Health Care입니다
Gerresheimer AG의 시가총액은 얼마입니까?
Gerresheimer AG의 현재 시가총액은 $1.1B입니다
Gerresheimer AG는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 22명의 분석가가 Gerresheimer AG에 대한 분석 평가를 실시했으며, 이는 4명의 강력한 매수, 10명의 매수, 9명의 보유, 0명의 매도, 그리고 4명의 강력한 매도를 포함합니다
